Latest filing published 16 May 2025 for Travere Therapeutics, Inc..
Insider track record
No signal scores available.
Sandra Poole: trading record in brief
All filings by Sandra Poole on record concern Travere Therapeutics, Inc., in the capacity of board member. We count 7 filings; the first trade dates from 13 May 2019 and the latest from 15 May 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 16 May 2025 with a share grant in Travere Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sandra Poole
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,500 shares0Common StockSEC:0001415889-25-013502:0
- 6,500 shares0Common StockSEC:0001415889-24-012850:0
- 4,500 shares0Common StockSEC:0001209191-23-030965:0
- 3,000 shares0Common StockSEC:0001209191-22-028701:0
- 3,000 shares0Common StockSEC:0001209191-21-033846:0
- 3,000 shares0Common StockSEC:0001209191-20-030745:0
- 3,500 shares0Common StockSEC:0001209191-19-030178:0
7 of 7 declarations
